Ultragenyx Pharmaceutical reported $0 in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acceleron Pharma XLRN:US $ 0M 0M
Agios Pharmaceuticals AGIO:US $ 0.17M 0.08M
Alexion Pharmaceuticals ALXN:US $ 2388.8M 30.8M
Alnylam Pharmaceuticals ALNY:US $ 433.15M 241.56M
Aptinyx Inc APTX:US $ 0 0
Biocryst Pharmaceuticals BCRX:US $ 254.34M 9.88M
Biomarin Pharmaceutical BMRN:US $ 1077.11M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Epizyme EPZM:US $ 230.5M 658K
Esperion Therapeutics ESPR:US $ 271.69M 92.33M
Gw Pharmaceuticals GWPH:US $ 14.16M 0.14M
Insmed INSM:US $ 375.99M 4.96M
IONIS PHARMACEUT IONS:US $ 870.92M 347.1M
Karyopharm Therapeutics KPTI:US $ 241.79M 50.78M
Macrogenics MGNX:US $ 0 0
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US $ 138M 28.13M
Neurocrine Biosciences NBIX:US $ 326.3M 4.3M
Ptc Therapeutics PTCT:US $ 1115.38M 3.45M
Puma Biotechnology PBYI:US $ 76.35M 7.68M
Regeneron Pharmaceuticals REGN:US $ 1978.9M 716.8M
Sarepta Therapeutics SRPT:US $ 1091.11M 98.62M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 524.92M 5.4M
Vital Therapies VTL:US $ 0M 0M
Xoma XOMA:US $ 11.65M 1.11M